Heron Therapeutics Stock News

SAN DIEGO, March 2, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that…

Heron Therapeutics had a productive 2021 with several corporate and commercial achievements that will set the company up for future growth.

The biotech's Q4 results didn't live up to expectations.

The biotech''s Q4 results didn''t live up to expectations.

Heron Therapeutics <> stock fell following in Q4 results.Q4 net product sales rose +0.24% Y/Y to $20.66M, which failed to beat analysts'' estimates. Net product sales for ZYNRELEF…

The biotech's Q4 results didn't live up to expectations.

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine, Inc. (NASDAQ: EDIT) sai

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 8.47% and 20.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics press release (HRTX): Q4 GAAP EPS of -$0.54 beats by $0.04.Revenue of $20.66M (+0.2% Y/Y) misses by $5.11M.

Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q4 2021 Results - Earnings Call Transcript

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 8.47% and 20.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ: LXRX ) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (NASDAQ: PRAX ) is likely to report earnings for its fourth quarter. • Blackstone Secured (NYSE: BXSL ) is likely to report quarterly earnings at $0.59 per share on revenue of $171.69 million. • Mersana Therapeutics (NASDAQ: MRSN ) is estimated to report earnings for its fourth quarter. • Partner Communications Co (NASDAQ: PTNR ) is expected to report earnings for its fourth quarter. • Daqo New Energy (NYSE: DQ ) is expected to report quarterly earnings at $4.58 per share on revenue of $698.65 million. • Easterly Government Props (NYSE: DEA ) is likely to report quarterly earnings at $0.10 per share on revenue of $72.20 million. • Aurinia Pharmaceuticals (NASDAQ: AUPH ) is expected to report earnings for its fourth quarter. • Kosmos Energy (NYSE: KOS ) is estimated to report quarterly earnings at $0.15 per share on revenue of $380.

Heron Therapeutics (NASDAQ:HRTX) is scheduled to announce Q4 earnings results on Monday, February 28th, after market close.The consensus EPS Estimate is -$0.56 and the consensus…

Heron Therapeutics Inc. (NASDAQ:HRTX) has a beta value of 1.32 and has seen 2.06 million shares traded in the last trading session. The company, currently valued at $791.90M, closed the last trade at $7.23 per share which meant it lost -$0.16 on the day or -2.17% during that session. The HRTX stock price is -182.85% Heron Therapeutics Inc. (HRTX) Is A Buy Stock For Small Caps Analysts Read More »